Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 889       

   Table of Contents      
BOOK REVIEW
Year : 2015  |  Volume : 142  |  Issue : 3  |  Page : 352

Proton pump inhibitors: A balanced view


Institute of Gastroenterology, SRM Institutes for Medical Science, 1 Jawaharlal Nehru Road, Vadapalani, Chennai 600 026, Tamil Nadu, India

Date of Web Publication6-Oct-2015

Correspondence Address:
B S Ramakrishna
Institute of Gastroenterology, SRM Institutes for Medical Science, 1 Jawaharlal Nehru Road, Vadapalani, Chennai 600 026, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Ramakrishna B S. Proton pump inhibitors: A balanced view. Indian J Med Res 2015;142:352

How to cite this URL:
Ramakrishna B S. Proton pump inhibitors: A balanced view. Indian J Med Res [serial online] 2015 [cited 2020 May 28];142:352. Available from: http://www.ijmr.org.in/text.asp?2015/142/3/352/166608

Proton pump inhibitors: A balanced view , T. Chiba, P, Malfertheiner, H. Satoh, editors (Karger, Basel, Switzerland) 2013. 120 pages. Price: US$ 209.00 / CHF 178.00 / EUR 148.00

ISBN 978-3-318-02415-9 (hard cover)

This book is the 32 nd volume of the ongoing series, Frontiers of Gastrointestinal Research and has been edited by three eminent personalities. The first chapter by Hiroshi Satoh traces the discovery and development of proton pump inhibitors (PPIs). The parent molecules for the drugs were thioacetamide derivatives, discovered almost simultaneously by two pharmaceutical companies, Takeda (Japan) and Servier (France). This chapter recounts how early toxicity in animals necessitated chemical modifications that led eventually to development and launch of omeprazole in 1988 by Astra and lansoprazole in 1991 by Takeda. The chapter goes on to follow developments till the present day. The pharmacokinetics, pharmacodynamics and pharmacogenetics of PPIs are comprehensively reviewed in the next chapter. Subsequent chapters deal with clinical applications, including tailoring of the dose to specific clinical conditions including gastroesophageal reflux disease (GERD), prevention and healing of non-steroidal analgesic-induced ulcers, and their role in eradication of Helicobacter pylori. The central role of parenteral or oral high dose PPIs in the management of bleeding peptic ulcer disease has been highlighted. The role of PPIs in functional dyspepsia, especially to relieve symptoms in undiagnosed gastroesophageal reflux disease has also been reviewed. Their supplementary use in the management of exocrine pancreatic insufficiency has been highlighted in the next chapter. Given the wide and somewhat indiscriminate use of PPIs, there is concern about their long term side effects. Both gastrointestinal and the systemic side effects of long term therapy of PPIs has been comprehensively dealt with in the last two chapters. In all, this is a compact and useful reference book that should find place in medical college and reference libraries.




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed308    
    Printed9    
    Emailed0    
    PDF Downloaded190    
    Comments [Add]    

Recommend this journal